Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent

MLA

Zhongmin Zhang, et al. “Preclinical Evaluation of Liposomal C8 Ceramide as a Potent Anti-Hepatocellular Carcinoma Agent.” PLoS ONE, vol. 11, no. 1, Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....07543632360920eefefb197166300809&authtype=sso&custid=ns315887.

APA

Zhongmin Zhang, Xiaoyu Wu, Xin Wang, Chenglin Li, Weihong Gong, Liang Gui, Huiqing Lv, & Yaoxia Wang. (2016). Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent. PLoS ONE, 11(1).

Chicago

Zhongmin Zhang, Xiaoyu Wu, Xin Wang, Chenglin Li, Weihong Gong, Liang Gui, Huiqing Lv, and Yaoxia Wang. 2016. “Preclinical Evaluation of Liposomal C8 Ceramide as a Potent Anti-Hepatocellular Carcinoma Agent.” PLoS ONE 11 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....07543632360920eefefb197166300809&authtype=sso&custid=ns315887.